ICON Plc (ICLR):企業の財務・戦略的SWOT分析

◆英語タイトル:ICON Plc (ICLR) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH8733FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:58
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥51,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ICON Plc (ICLR) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides specialized services that span the entire lifecycle of product development. The company’s service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, functional services provision, medical imaging, laboratory services, resourcing solutions and strategic support and tactical solutions for traditional, in vitro diagnostic and software devices. The company offers research services in areas of cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, nonalcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines and women’s health therapeutics areas among others. ICON is headquartered in Dublin, Ireland.

ICON Plc Key Recent Developments

Feb 24,2021: Ireland’s ICON signs agreement to acquire PRA Health Sciences
Oct 21,2020: Icon reports third quarter 2020 results
Oct 19,2020: BARDA reselects ICON as preferred partner to help strengthen US emergency preparedness and response
Oct 07,2020: ICON wins best CRO at the vaccine industry excellence wwards
Sep 03,2020: ICON launches Accellacare a global clinical research network focused on increasing patient recruitment with a patient centric approach

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ICON Plc – Key Facts
ICON Plc – Key Employees
ICON Plc – Key Employee Biographies
ICON Plc – Major Products and Services
ICON Plc – History
ICON Plc – Company Statement
ICON Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ICON Plc – Business Description
Geographical Segment: Ireland
Performance
Geographical Segment: Other
Performance
Geographical Segment: Rest of Europe
Performance
Geographical Segment: US
Performance
ICON Plc – Corporate Strategy
ICON Plc – SWOT Analysis
SWOT Analysis – Overview
ICON Plc – Strengths
ICON Plc – Weaknesses
ICON Plc – Opportunities
ICON Plc – Threats
ICON Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ICON Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ICON Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 21, 2020: Icon reports third quarter 2020 results
Oct 19, 2020: BARDA reselects ICON as preferred partner to help strengthen US emergency preparedness and response
Oct 07, 2020: ICON wins best CRO at the vaccine industry excellence wwards
Sep 03, 2020: ICON launches Accellacare a global clinical research network focused on increasing patient recruitment with a patient centric approach
Jul 22, 2020: ICON reports second qquarter 2020 results
May 05, 2020: ICON appoints new Chief Medical Officer
Apr 22, 2020: ICON reports first quarter 2020 results
Apr 09, 2020: ICON wins multiple categories in 2020 CRO Leadership Awards third year in a row
Apr 03, 2020: ICON signs new service agreement with Pfizer
Mar 23, 2020: ICON launches the coronavirus observatory
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ICON Plc, Key Facts
ICON Plc, Key Employees
ICON Plc, Key Employee Biographies
ICON Plc, Major Products and Services
ICON Plc, History
ICON Plc, Subsidiaries
ICON Plc, Key Competitors
ICON Plc, Ratios based on current share price
ICON Plc, Annual Ratios
ICON Plc, Annual Ratios (Cont...1)
ICON Plc, Annual Ratios (Cont...2)
ICON Plc, Interim Ratios
ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
ICON Plc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
ICON Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[ICON Plc (ICLR):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Wendy’s Company:企業の戦略・SWOT・財務情報
    The Wendy’s Company - Strategy, SWOT and Corporate Finance Report Summary The Wendy’s Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • STATS ChipPAC Pte Ltd:企業の戦略的SWOT分析
    STATS ChipPAC Pte Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Hostess Brands, Inc. (TWNK):企業の財務・戦略的SWOT分析
    Hostess Brands, Inc. (TWNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Continental Grain Co:企業の戦略的SWOT分析
    Continental Grain Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Air China Limited:企業のM&A・事業提携・投資動向
    Air China Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Air China Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Aptose Biosciences Inc (APTO):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptose Biosciences Inc (Aptose) is a clinical-stage biotechnology company which focuses on diagnostics, therapies and treatment for patients with life-threatening cancers. The company advances in new therapeutics which focuses on cellular targets of cancer research coupled with companion dia …
  • The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C):企業の戦略・SWOT・財務情報
    The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C) - Strategy, SWOT and Corporate Finance Report Summary The Mediterranean & Gulf Cooperative Insurance & Reinsurance Company (S.J.S.C) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data …
  • Actelion Ltd:企業の戦略・SWOT・財務分析
    Actelion Ltd - Strategy, SWOT and Corporate Finance Report Summary Actelion Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • NTPC Ltd (NTPC):石油・ガス:M&Aディール及び事業提携情報
    Summary NTPC Ltd (NTPC) is a Public sector undertaking energy conglomerate. It has presence in the entire value chain of the power generation business. The company produces electricity and sells that to state power utilities on wholesale basis. NTPC generates power using coal, gas, liquid fuel and h …
  • Merz Pharma GmbH & Co KgaA-医療機器分野:企業M&A・提携分析
    Summary Merz Pharma GmbH & Co KgaA (Merz Pharma) is an aesthetics and neurotoxin company that develops products for aesthetic and medical dermatology and neurological movement disorders. The company’s products include aesthetics, ethical drugs, over-the-counter drugs, neurology, and central nervous …
  • Sumitomo Realty & Development Co., Ltd.:企業の戦略・SWOT・財務情報
    Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Lidds AB (LIDDS):製薬・医療:M&Aディール及び事業提携情報
    Summary Lidds AB (Lidds) is a developer of pharmaceutical products for the treatment of cancer and other diseases. The company offers Liproca Depot, an injectable product used for the treatment of prostate cancer. Its Liproca is a bioresorbable, biocompatible and locally injectable modified release …
  • Bose Corporation:企業の戦略・SWOT・財務情報
    Bose Corporation - Strategy, SWOT and Corporate Finance Report Summary Bose Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SDN Company Ltd (099220):電力:M&Aディール及び事業提携情報
    Summary SDN Company Ltd (SDN Company), formerly Seoul Marine Co Ltd is a diversified company that operates through its business divisions such as photovoltaic, engine, and shipbuilding divisions. The company’s photovoltaic business division manufactures solar inverters, solar panels, solar trackers, …
  • Massachusetts Eye and Ear Infirmary-製薬・医療分野:企業M&A・提携分析
    Summary Massachusetts Eye and Ear Infirmary (MEE) is a healthcare service provider that offers primary, medical and surgical care services. The hospital offers services through departments such as ophthalmology, otolaryngology and patient care services. Its patient care services include patient educ …
  • GEO Specialty Chemicals Inc:企業の戦略的SWOT分析
    GEO Specialty Chemicals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Imaging Dynamics Company Ltd (IDL):医療機器:M&Aディール及び事業提携情報
    Summary Imaging Dynamics Company Ltd (IDC) is a medical device company that offers medical imaging and digital radiography technology solutions. The company provides detector series, proprietary software and DR series products. Its software products include Magellan medical image processing software …
  • DigitalGlobe Inc:企業の戦略的SWOT分析
    DigitalGlobe Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Caesars Entertainment Corporation:企業の戦略・SWOT・財務情報
    Caesars Entertainment Corporation - Strategy, SWOT and Corporate Finance Report Summary Caesars Entertainment Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Aduro BioTech Inc (ADRO):企業の財務・戦略的SWOT分析
    Summary Aduro BioTech Inc (Aduro BioTech) is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆